Peer-reviewed evidence.
Read the source.
Research summaries on the compounds, delivery science, and clinical applications behind OptiOral Care formulations. Every claim cites the underlying publication.
Ac-AEDG-NH₂ in Human Gingival Mesenchymal Stem Cells
A 2020 peer-reviewed study published in Molecules (Khavinson et al.) demonstrated that AEDG produced significant reductions in cellular senescence markers p16 and p21 in human gingival mesenchymal stem cells (hGMSCs). The findings provide direct mechanistic evidence for AEDG's role in restoring proliferative capacity in oral stem cells — the cells responsible for gingival tissue self-renewal.
Compound ReviewAEDG in Human Periodontal Ligament Stem Cells
Sinjari et al., publishing in Stem Cell Reviews and Reports in 2020, examined AEDG exposure in human periodontal ligament stem cells (hPDLSCs) across multiple replicative passages. The study documented restoration of proliferative capacity past the replicative passage limits typical of senescing PDL stem cells — the cellular substrate of periodontal ligament regeneration.
Compound ReviewAc-KE-NH₂ and NFκB in Periodontal Disease
Periodontal disease and peri-implantitis are immune dysregulation diseases. Continued bacterial load alone does not account for progressive tissue destruction — host inflammatory response drives alveolar bone resorption through NFκB-mediated cytokine signaling. Ac-KE-NH₂ directly modulates this transcription factor.
Compound ReviewGHK in Human Saliva and Oral Tissue Repair
GHK (Gly-His-Lys) is a tripeptide naturally present in human plasma and saliva. Salivary concentration declines more than 60% between age 20 and 60 — paralleling the timeline of reduced oral wound healing capacity. Comparative human trials with biopsy confirmation show GHK induces collagen synthesis in 70% of subjects, exceeding the response rate of Vitamin C (50%) and retinoic acid (40%).
Delivery ScienceBuccal Mucosal Delivery of Short-Chain Peptides
The oral mucosa is a highly vascularized absorptive surface with direct access to the sublingual venous plexus. Short-chain peptides of 2–7 amino acids are absorbed transmucosally at clinically relevant concentrations during a 60–90 second hold. Mucoadhesive vehicles and chitosan-based tight junction modulators extend exposure into the subepithelial tissue.
Delivery ScienceDual-Terminus Modification: Why Ac-X-NH₂ for Oral Delivery
The oral environment contains aminopeptidases and carboxypeptidases that rapidly cleave native peptide sequences from both the N- and C-termini, limiting therapeutic exposure to minutes. The Ac-X-NH₂ analogs in OptiOral Care formulations carry N-terminal acetylation and C-terminal amidation — modifications that block both proteolytic attack points and extend active compound half-life from minutes to hours. This is the key innovation enabling therapeutic tissue exposure from a non-injectable oral format.
Clinical ApplicationPeri-Implantitis: The Two-Component Biological Approach
Peri-implantitis treatment outcomes are limited by the gap between mechanical decontamination and biological re-establishment of the peri-implant tissue interface. Mechanical therapy addresses biofilm but does not modulate the NFκB-driven inflammatory environment or restore the soft tissue collar around the implant. A peptide adjunct addresses both biological components.